Mogamulizumab-kpkc Intravenous and Oracit
Determining the interaction of Mogamulizumab-kpkc Intravenous and Oracit and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: citric acid / sodium citrate
Brand name: Bicitra, Cytra-2, Liqui-Dual Citra, Oracit, Shohl's Solution, Virtrate-2
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Orajel
- Mogamulizumab-kpkc Intravenous-Orajel Extra Strength
- Mogamulizumab-kpkc Intravenous-Oral Gel
- Mogamulizumab-kpkc Intravenous-Oralair
- Mogamulizumab-kpkc Intravenous-Oralair Adult Sample Kit
- Mogamulizumab-kpkc Intravenous-Oralair Childrens and Adolescents Sample Kit
- Oracit-Molindone
- Oracit-Mometasone (Oral Inhalation)
- Oracit-Mometasone and Formoterol
- Oracit-Mometasone and formoterol Inhalation
- Oracit-Mometasone Cream
- Oracit-Mometasone Furoate